↓ Skip to main content

The peroxisome proliferator-activated receptor (PPAR) alpha agonist fenofibrate maintains bone mass, while the PPAR gamma agonist pioglitazone exaggerates bone loss, in ovariectomized rats

Overview of attention for article published in BMC Endocrine Disorders, May 2011
Altmetric Badge

Citations

dimensions_citation
57 Dimensions

Readers on

mendeley
52 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The peroxisome proliferator-activated receptor (PPAR) alpha agonist fenofibrate maintains bone mass, while the PPAR gamma agonist pioglitazone exaggerates bone loss, in ovariectomized rats
Published in
BMC Endocrine Disorders, May 2011
DOI 10.1186/1472-6823-11-11
Pubmed ID
Authors

Astrid K Stunes, Irene Westbroek, Björn I Gustafsson, Reidar Fossmark, Jan H Waarsing, Erik F Eriksen, Christiane Petzold, Janne E Reseland, Unni Syversen

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 52 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 52 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 11 21%
Researcher 9 17%
Student > Master 8 15%
Student > Bachelor 6 12%
Student > Doctoral Student 3 6%
Other 4 8%
Unknown 11 21%
Readers by discipline Count As %
Agricultural and Biological Sciences 11 21%
Biochemistry, Genetics and Molecular Biology 7 13%
Medicine and Dentistry 6 12%
Pharmacology, Toxicology and Pharmaceutical Science 5 10%
Immunology and Microbiology 2 4%
Other 6 12%
Unknown 15 29%